Pharmacogenomics

Pharmacogenomics is a piece of a field called customized solution that means to tweak human services, with choices and medications custom-made to every individual patient inside and out conceivable. Pharmacogenomics and pharmacogenomics manage new developments in the field of customized meds and advancements in modified medication revelation utilizing proteome innovation.

Pharmacogenomics aims to customize health care, with decisions and treatments tailored to each individual patient in every way possible. Genomic testing is still a relatively new development in drug treatment, this field is expanding. Currently, more than 100 drugs have label information regarding pharmacogenomics biomarkers. This information is used to improve the selection and dosage of drugs to treat a wide range of conditions, including cardiovascular disease, lung disease, HIV infection, cancer, arthritis, high cholesterol and depression.

  • Pharmacotherapy
  • Pharmacokinetics
  • Personalized Medicine
  • Drug-metabolizing enzymes

Related Conference of Pharmacogenomics

December 07-08, 2021

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 09-10, 2021

2nd International Conference on Geriatrics and Ageing

Sydney, Australia
December 10-10, 2021

8th World Congress on Epigenetics and Chromosome

London, UK
December 16-16, 2021

4th Annual Conference on Stem Cell and Regenerative Medicine

Amsterdam, Netherlands
March 10-11, 2022

14th World Congress on Stem Cell Research

Paris, France
April 14-15, 2022

15th World Conference on Human Genomics and Genomic Medicine

Singapore City, Singapore
April 14-15, 2022

9th World Congress on Human Genetics and Genetic Diseases

Singapore City, Singapore
July 11-12, 2022

26th Global Congress on Biotechnology

Vienna, Austria
October 17-18, 2022

21st International Conference on Structural Biology

Barcelona, Spain

Pharmacogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in